Nuclear Medicine: Page 2

Stanford Medicine appoints Umar Mahmood chair of radiology

By AuntMinnie.com staff writers

Mahmood's appointment follows a national search.

August 29, 2025

Radiopharmaceutical production gets boost from radium transfers to U.S.

By AuntMinnie.com staff writers

Legacy sources will significantly add to actinium-225 (Ac-225) production.

August 22, 2025

Nusano opens flagship radioisotope production facility in Utah

By AuntMinnie.com staff writers

The facility will support domestic radiopharmaceutical manufacturing.

August 22, 2025

SNMMI praises Senate for including nuclear medicine language in reports

By AuntMinnie.com staff writers

The SNMMI is lauding the Senate Appropriations Committee for including nuclear medicine research language in its 2026 fiscal reports.

August 21, 2025

International Isotopes posts Q2 revenue increase

By AuntMinnie.com staff writers

The increase was partially due to the remedying of the global shortage of cobalt-57 isotope.

August 13, 2025

DOE, state of Missouri, University of Missouri to collaborate

By AuntMinnie.com staff writers

Funding raised in the partnership will support a new radioisotope development center at Discovery Ridge in Columbia.

August 11, 2025

GT Medical Technologies secures $53M in funding

By AuntMinnie.com staff writers

Medical device developer GT Medical Technologies has secured $53 million in financing.

July 15, 2025

SNMMI: New PET tracers developed for imaging brain disorders

By Will Morton

Two newly developed PET imaging agents are effective for identifying a highly expressed receptor in neurological and psychiatric conditions.

June 21, 2025

Ratio Therapeutics partners with Macrocyclics

By AuntMinnie.com staff writers

The agreement will enable access to Macropa in Japan, Canada, Australia, and a majority of Europe, according to Ratio.

June 13, 2025

Positrigo closes $8.5M funding round

By AuntMinnie.com staff writers

Firm also notes board changes.

June 10, 2025

Radium-223 safety confirmed in long-term study

By Erik L. Ridley

At ASCO 2025, researchers shared data on the long-term safety of Ra-223 treatments for metastatic castration-resistant prostate cancer.

June 2, 2025

Clarity highlights first patient imaged in Amplify trial

By AuntMinnie.com staff writers

Clarity Pharmaceuticals has imaged the first patient in its phase III Amplify trial at XCancer in Omaha, NE.

May 29, 2025

Previous Page

Page 2 of 439

Next Page